Article
Molecular Basis of the Schuurs-Hoeijmakers Syndrome: What We Know about the Gene and the PACS-1 Protein and Novel Therapeutic Approaches.
International journal of molecular sciences - 25 Aug 2022
Arnedo María, Ascaso Ángela, Latorre-Pellicer Ana, Lucia-Campos Cristina, Gil-Salvador Marta, Ayerza-Casas Ariadna, Pablo María Jesús, Gómez-Puertas Paulino, Ramos Feliciano J, Bueno-Lozano Gloria, Pié Juan, Puisac Beatriz
Abstract excerpt
The Schuurs−Hoeijmakers syndrome (SHMS) or PACS1 Neurodevelopment Disorder (PACS1-NDD) is a rare autosomal dominant disease caused by mutations in the PACS1 gene. To date, only 87 patients have been reported and, surprisingly, most of them carry the same variant (c.607C>T; p.R203W). The most relevant clinical features of the syndrome include neurodevelopment delay, seizures or a recognizable facial phenotype....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
